{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"71"}]}],"title":"Total number who received aMILS"},{"categories":[{"measurements":[{"groupId":"OG000","value":"46"}]}],"title":"Feasible"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Reason not feasible- failed harvest"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}],"title":"Reason not feasible- disease progression"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Reason not feasible- death"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Reason not feasible- lost to follow-up"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Reason not feasible- failed expansion"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Reason not feasible- cell product contamination"},{"categories":[{"measurements":[{"groupId":"OG000","value":"14"}]}],"title":"Reason not feasible- greater than 120 days"}],"denoms":[{"counts":[{"groupId":"OG000","value":"71"}],"units":"Participants"}],"description":"Feasibility is defined as the ability to harvest, expand, and infuse the MILs product within 120 days. After treating 60 patients with MILs, we will declare MILs not feasible if we can only harvest, expand, and deliver MILs to 40 or fewer patients.","groups":[{"description":"Patients receive activated Marrow Infiltrating Lymphocytes (aMIL)\n\naMIL: On day 0, patients will receive auto transplant followed by Tadalafil and aMIL. At day 60, patients will receive Lenalidomide.","id":"OG000","title":"aMIL Arm"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"71 patients were evaluable in the feasibility set: 70 randomized to the aMILs Arm, plus one patient who was not randomized due to harvest failure.","reportingStatus":"POSTED","timeFrame":"120 days","title":"Feasibility of MILs as Assessed by the Ability to Harvest, Expand, and Infuse the MILs Product","type":"PRIMARY","unitOfMeasure":"Participants"}